Naloxone

Take Home Naloxone in the UK

Naloxone (provided under the brand names Prenoxad and Nyxoid in the UK) is a medication used to reverse opioid overdose. Since 2015, this medication has been more widely available in the UK as a ‘take home’ emergency medication.

NALOXONE.ORG.UK

This website aims to be a hub for information, guidance, news and research on Take Home Naloxone (THN). The main focus is on THN in the UK, although we have included select pieces of information on the supply of naloxone internationally.

PHE Guidance

Updated 18 February 2019
Public Health England have released updated guidance on take home naloxone in the UK, entiled ‘Widening the Availability of Naloxone’. This can be found on the PHE website.
  • Drug services can supply naloxone without a prescription
  • Products that drug services can supply
  • Responsibility for deciding who can supply naloxone
  • People who can be supplied naloxone by a drug service
  • Using naloxone to save a person’s life without their permission
  • Clinical governance in drug treatment services
  • Guidance for hostels, homeless shelters and housing associations
  • Side effects associated with naloxone

Middle-aged generation most likely to die by suicide and drug poisoning

Written on . Posted in , .

A generation of people born in the 1960s and 1970s, known as Generation X, are dying from suicide or drug poisoning in greater numbers than ever. ONS data for England and Wales has shown that in the late 1980s to early 1990s, the age at which most people died by taking their own lives or drug poisoning was concentrated around this generation, when they were in their 20s.

Stop the deaths

This year the Scottish Drugs Forum  #StopTheDeaths campaign highlights the role we all have in recognising and intervening when a person overdoses.

Overdose is not a rare occurrence and the difference between an overdose and a fatal overdose depends upon the immediate actions of people present at the time. You could save a life by recognising an overdose.  

#StopTheDeaths images © SDF 2021

News/Updates

White House: A Proclamation on Overdose Awareness Week, 2021

Written on . Posted in .

The overdose epidemic has taken a toll on far too many Americans and their loved ones. Addiction is a disease that touches families in every community, including my own. The epidemic is national, but the impact is personal. It is personal to the millions who confront substance use disorder every day, and to the families who have lost loved ones to an overdose.

During Overdose Awareness Week, we recommit to taking bold actions to prevent overdoses and related deaths, and enhance our support for individuals with substance use disorders.

Proposal to give more nurses right to hand out overdose-reversal medicine

Written on . Posted in , .

The government wants to give more nurses access to a life-saving medication that can reverse the effects of an opioid overdose, in a bid to curb spiralling numbers of drug-related deaths. A consultation has been launched to amend current regulations in order to allow a wider group of professionals to hold naloxone and give it out to individuals to keep in the event of a future overdose.

Proposal to give more nurses right to hand out overdose-reversal medicine

Written on . Posted in , .

The government wants to give more nurses access to a life-saving medication that can reverse the effects of an opioid overdose, in a bid to curb spiralling numbers of drug-related deaths. A consultation has been launched to amend current regulations in order to allow a wider group of professionals to hold naloxone and give it out to individuals to keep in the event of a future overdose.

Open Consultation

Expanding Access To Naloxone

Consultation Deadline: 11:45pm on 28 September 2021

The UK Government are seeking responses to their consultation to assess the viability of proposals to widen access to naloxone by expanding the list of services and individuals that can give it out without a prescription or other written instruction.

Who is Consulting: UK Government
Who is being consulted: They welcome responses from individuals or organisations who have experience or expertise in substance use disorders.

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT